{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:33:19Z","timestamp":1789788799987,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003268","name":"Toa Pharmaceutical","doi-asserted-by":"publisher","award":["AK194070"],"award-info":[{"award-number":["AK194070"]}],"id":[{"id":"10.13039\/501100003268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.alit.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T18:38:44Z","timestamp":1727375924000},"page":"222-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cytokine profile of the stratum corneum in atopic dermatitis lesions differs between the face and the trunk"],"prefix":"10.1016","volume":"74","author":[{"given":"Makiko","family":"Kido-Nakahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Ibusuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsunaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kuba-Fuyuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2024.08.010_bib1","first-page":"97","article-title":"Pathogenesis of atopic dermatitis: current paradigm","volume":"16","author":"Furue","year":"2019","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.alit.2024.08.010_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.alit.2016.12.002","article-title":"Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies","volume":"66","author":"Furue","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2024.08.010_bib3","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/all.12049","article-title":"Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine","volume":"67","author":"Bieber","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.010_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/pde.14437","article-title":"Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: clinical aspects and treatment outcomes in adolescent and adult patients","volume":"38","author":"Guglielmo","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.07.058","article-title":"The role of Malassezia in atopic dermatitis affecting the head and neck of adults","volume":"60","author":"Darabi","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40257-022-00685-0","article-title":"Dupilumab provides acceptable safety and sustained efficacy for up to 4 years in an open-label study of adults with moderate-to-severe atopic dermatitis","volume":"23","author":"Beck","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib7","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"10","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2024.08.010_bib8","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2024.08.010_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/bjd.17703","article-title":"Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials","volume":"181","author":"Blauvelt","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib10","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/jdv.18327","article-title":"Facial erythema in patients with atopic dermatitis treated with dupilumab - a descriptive study of morphology and aetiology","volume":"36","author":"Ahn","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2024.08.010_bib11","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaad.2021.01.012","article-title":"Facial and neck erythema associated with dupilumab treatment: a systematic review","volume":"84","author":"Jo","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/DER.0000000000000590","article-title":"A\u00a0practical approach to recalcitrant face and neck dermatitis in atopic dermatitis","volume":"31","author":"Jaros","year":"2020","journal-title":"Dermatitis"},{"key":"10.1016\/j.alit.2024.08.010_bib13","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v101.369","article-title":"Efficacy of dupilumab for atopic dermatitis according to clinical course and clinical findings: a multicentre retrospective study","volume":"101","author":"Nakahara","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2024.08.010_bib14","first-page":"4431","article-title":"The JAK\/STAT pathway and its selective inhibition in the treatment of atopic dermatitis: a systematic review","volume":"11","author":"Tsiogka","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.alit.2024.08.010_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.010_bib16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/biomedicines11051303","article-title":"Novel therapeutic targets for the treatment of atopic dermatitis","volume":"11","author":"Tsuji","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.alit.2024.08.010_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/bjd\/ljac016","article-title":"Insights into atopic dermatitis pathogenesis lead to newly approved systemic therapies","volume":"188","author":"Trier","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib18","first-page":"6145","article-title":"The dawn of a new era in atopic dermatitis treatment","volume":"11","author":"Yamamura","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.alit.2024.08.010_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.17231","article-title":"Tralokinumab-related facial redness: a therapeutic challenge","author":"Garc\u00eda-Gonz\u00e1lez","year":"2024","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1196\/annals.1443.021","article-title":"Regulation and function of proinflammatory Th17 cells","volume":"1143","author":"Martinez","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.alit.2024.08.010_bib21","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.jaad.2017.12.019","article-title":"Emerging therapies for atopic dermatitis: JAK inhibitors","volume":"78","author":"Cotter","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2242540","article-title":"Effectiveness and safety of upadacitinib in patients with face and neck atopic dermatitis unresponsive to dupilumab","volume":"34","author":"Yang","year":"2023","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.alit.2024.08.010_bib23","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1111\/jdv.17705","article-title":"Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib","volume":"36","author":"Licata","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2024.08.010_bib24","article-title":"Microbiome and lipidomic analysis reveal the interplay between skin bacteria and lipids in a cohort study","volume":"15","author":"Li","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.alit.2024.08.010_bib25","doi-asserted-by":"crossref","first-page":"16608","DOI":"10.1021\/acs.analchem.1c03983","article-title":"Molecular mapping of sebaceous squalene by ambient mass spectrometry","volume":"93","author":"Cho","year":"2021","journal-title":"Anal Chem"},{"key":"10.1016\/j.alit.2024.08.010_bib26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1346-8138.2010.00913.x","article-title":"Cutaneous Malassezia microbiota of healthy subjects differ by sex, body part and season","volume":"37","author":"Akaza","year":"2010","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0190-9622(82)70137-9","article-title":"Demodex folliculorum and Demodex brevis in cutaneous biopsies","volume":"7","author":"Aylesworth","year":"1982","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2024.08.010_bib28","first-page":"1057","article-title":"Microbiome: role in inflammatory skin diseases","volume":"17","author":"Zhang","year":"2024","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.alit.2024.08.010_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.chom.2019.02.002","article-title":"The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation","volume":"25","author":"Sparber","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.alit.2024.08.010_bib30","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jaci.2022.11.023","article-title":"Skin TARC\/CCL17 increase precedes the development of childhood atopic dermatitis","volume":"151","author":"Halling","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.010_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/all.15518","article-title":"Skin biomarkers predict development of atopic dermatitis in infancy","volume":"78","author":"Rinnov","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2024.08.010_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2020.05.048","article-title":"Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis","volume":"147","author":"He","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2024.08.010_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000448400","article-title":"Stratum corneum tape stripping: monitoring of inflammatory mediators in atopic dermatitis patients using topical therapy","volume":"170","author":"Koppes","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2024.08.010_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000339666","article-title":"Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis","volume":"160","author":"Amarbayasgalan","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2024.08.010_bib35","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3389\/fimmu.2020.01768","article-title":"Tape-strip proteomic profiling of atopic dermatitis on dupilumab identifies minimally invasive biomarkers","volume":"11","author":"He","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2024.08.010_bib36","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1398-9995.2010.02361.x","article-title":"Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis","volume":"65","author":"Morita","year":"2010","journal-title":"Allergy"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893024001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893024001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:49:05Z","timestamp":1762368545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893024001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1323893024001114"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2024.08.010","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine profile of the stratum corneum in atopic dermatitis lesions differs between the face and the trunk","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Allergology. Published by Elsevier B.V\u00e9","name":"copyright","label":"Copyright"}]}}